Spermatogenesis is a complex cellular process regulated by gonadotrophins and local cell-cell interactions. Stem cell factor (SCF) is one of the paracrine factors, produced by the Sertoli cells, involved in the local regulation of spermatogenesis. Measurement of its testicular level is important for addressing its role in testis physiopathology. However, the relative cell composition of experimental and pathological testis samples may lead to misinterpretation in relating SCF mRNA levels to the amount of RNA extracted from the whole tissue sample. Taking into account the relative RNA content of Sertoli cell origin should provide more significant data. In the present study, three sets of experiments were intended for modifying the proportion of RNA of Sertoli cell origin in RNA extracted from whole testis tissue samples: during postnatal development; following methoxy-acetic acid (MAA) administration; and after injecting a long-acting gonadotrophin-releasing hormone agonist (GnRHa). In a first step, we demonstrated clusterin mRNA level stability in purified Sertoli cell preparations between 20 days and adulthood, and following MAA or GnRHa treatment. In a second step, we used a competitive RT-PCR assay to measure SCF and clusterin mRNA levels and expressed the amount of SCF mRNA relative to the amount of clusterin mRNA under the above experimental conditions. The SCF/clusterin mRNA level ratio was found to remain roughly stable from 20 days post-partum to adulthood; i.e. during the development of spermatogenesis. MAA administration led to an overall increase in the SCF/clusterin mRNA level ratio between 7 and 14 days after administration, consistent with the replenishment of the testis with pachytene spermatocytes and round spermatids. Conversely, after long-acting GnRHa injection, the SCF/clusterin mRNA level ratio decreased only slightly from day 21 onward. Hence, the present studies indicate that, under physiopathological conditions, the amount of clusterin mRNA is a good marker of the amount of RNA of Sertoli cell origin in testis samples at day 20 or later; different experimental alterations of spermatogenesis are associated with different patterns of SCF mRNA levels; the relationship between FSH and SCF in vivo is not as simple as that described in vitro.
Introduction
Spermatogenesis is a complex cellular process involving stem cell multiplication and differentiation, genome reorganisation during meiosis, and a very specific cytodifferentiation to produce highly specialised sperm cells. This process is regulated by gonadotrophins acting on Leydig and Sertoli cells, which regulate germ cell differentiation by local interactions (Parvinen 1982 , Skinner 1991 , Kierszenbaum 1994 . The blood-testis barrier isolates the germ cells in a specific environment mainly controlled by the Sertoli cells. Sertoli cells produce several signalling molecules acting in a paracrine manner on the developing germ cells (Gnessi et al. 1997) . The relative importance of the various paracrine factors in regulating the various steps of the spermatogenic process, the regulation of their production and their potential abnormalities in spermatogenic failure have not yet, however, been determined precisely. Measuring the production of these paracrine factors in experimental and pathological conditions is of importance in order to address some of these issues.
Stem cell factor (SCF) is one of these factors produced by the Sertoli cells (Rossi et al. 1991) . It is involved in regulating spermatogonial proliferation (Rossi et al. 1993) , but also in later stages of spermatogenesis (Vincent et al. 1998) and in reducing germ cell apoptosis (Yan et al. 2000) . Like most paracrine factors, SCF mRNA has been quantified from RNA extracted from the whole testis (Rossi et al. 1993 , Hakovirta et al. 1999 , Goddard et al. 2001 . However, the cellular heterogeneity of the testis and its variations in experimental and pathological samples may cause misinterpretation in relating data to the amount of RNA extracted from the whole tissue sample. Taking into account the relative content of RNA of Sertoli cell origin should provide more significant data.
Clusterin, also referred to, among other names, as sulphated glycoprotein 2 (Tenniswood et al. 1998) , has been shown to be produced within the testis by the Sertoli cells (Morales et al. 1987) , and clusterin mRNA levels have been shown to be unmodified by germ cells or gonadotrophins in Sertoli cell cultures (Hugly et al. 1988 , Roberts et al. 1991 , 1992 . In order to measure accurately the mRNA levels of paracrine factors produced by the Sertoli cell, such as SCF, we sought to assess the use of the clusterin mRNA level as a marker of the amount of mRNA of Sertoli cell origin. Testicular tissue was obtained from three sets of experiments in rats, in which variations in the number and/or volume of somatic cells and/or germ cells have been described: (1) during postnatal development which is characterised by the dramatic growth and differentiation of the germ cell (Zhengwei et al. 1990 ) and interstital cell (Ariyaratne & Chamindrani Mendis-Handagama 2000) populations, and the functional maturation of Sertoli cells -the number of which remains constant from about 15 days post-partum onward (Wang et al. 1989 , Zhengwei et al. 1990 ); (2) following administration of methoxy-acetic acid (MAA), a toxin specific for spermatocytes which induces an acute spermatocyte depletion followed by a repopulation wave from spermatogonia (Li et al. 1996) and modest rarefaction and slight vacuolisation of Sertoli cells (Chapin & Lamb 1984) ; (3) after one injection of a long-acting gonadotrophinreleasing hormone agonist (GnRHa), which leads to down-regulation of gonadotrophin secretion inducing Sertoli cell functional alterations, but no change in their number, resulting in a progressive germ cell depletion (Pelletier et al. 1978 , Rivier et al. 1979 . These developmental or experimental modifications of the relative number/volume, differentiation status and function of the different testicular cell types were expected to change the proportion of RNA of Sertoli cell origin in RNA extracted from whole testis samples.
In a first step, we established that, from 20 days of age onward, and under both our experimental treatments of adult rats, clusterin mRNA levels remained stable in purified Sertoli cell preparations and conversely varied in whole testicular tissue samples. This suggested that clusterin mRNA may be used as a marker of the amount of RNA of Sertoli cell origin. Thus, in a second step, we used a competitive RT-PCR assay to measure SCF and clusterin mRNA under the above experimental conditions and expressed the amount of SCF mRNA relative to the amount of clusterin mRNA.
Materials and Methods

Animals
Sprague-Dawley rats were used throughout. They were maintained at 20 C in a fixed 12 h light:12 h darkness cycle with free access to food and water. The experiments were conducted according to our institution's Guide of Care and Use of Laboratory Animals. All procedures were approved by the Scientific Research Agency (Approval No., 69306) . Rats were killed by decapitation and their testes were rapidly removed.
Developmental study
Testes were obtained from 10-, 20-, 30-, 40-, 60-and 90-day-old rats.
MAA treatment
Testes were obtained 3, 7 and 14 days after a single i.p. injection of MAA (650 mg/kg body weight) to adult (90-day old) rats. MAA (Sigma) was dissolved in sterile water and adjusted to pH 7·0 by NaOH.
GnRH agonist treatment
Testes were obtained 2, 3 and 4 weeks after a single i.m. injection of 1·5 mg of a long-acting preparation of -Trp6-GnRH (Decapeptyl; kindly provided by Ipsen Biotech, France) to adult (90-day-old) rats.
Testicle histology
After multipuncture of the albuginae, one testis was immersed in Bouin's solution in each experimental condition. The fixed testicular tissue was paraffin-embedded, cut at 5 µm and stained with periodic acid Schiff (PAS).
Isolation of Sertoli cells
Since the number of Sertoli cells per testis was rather similar under the three experimental conditions tested (Pelletier et al. 1978 , Rivier et al. 1979 , Chapin & Lamb 1984 , Zhengwei et al. 1990 , the number of testes used for Sertoli cell purification ranged between 20 and 30 in each experiment. Testes were decapsulated and collected in Ham's F-12/Dulbecco's modified Eagle's medium (F-12/ DMEM, 1:1) (Gibco) supplemented with 15 mM Hepes, NaHCO 3 (1·2 g/l) and containing 1 mg/ml collagenase (Serva Biowhittaker, Fontenay-sous-Bois, France), 5 µg/ml DNAse (Sigma) and 0·5 µg/ml soybean trypsine inhibitor (Sigma). Digestion was performed for 20 min at 34 C under constant agitation. The seminiferous tubules were cut in small fragments, sedimented twice and further digested as above for 15 min. The remaining fragments were sedimented again and further fragmented by passing slowly through a 19-gauge syringe needle. This led to disruption of the tubular structures allowing the progressive removal of germ cells out of the tubule fragments. These fragmentation-sedimentation cycles were repeated until the number of isolated germ cells was reduced to a low value (see below); for adult rats, because of the high number of germ cells in testes, five to eight fragmentation-sedimentation cycles were necessary instead of the two to three used for young animals.
Immunocytochemistry
Vimentin immunoreactivity was used to determine the percentage of germ cells (vimentin-negative) contaminating the (vimentin-positive) Sertoli cell preparations (Oke & Suarez-Quian 1993 ). An aliquot of each Sertoli cell preparation was cytospun onto aminoalkylsilanised slides. The cells were fixed in Bouin's solution, and rinsed twice with ethanol (70%) then once with NaCl 0·9%. Cell membranes were permeabilised with 0·03% Triton X-100. An anti-vimentin specific monoclonal antibody (Dako, France) was used at a dilution of 1:1000. Vimentin immunoreactivity was revealed by a biotin-coupled goat anti-mouse antibody incubated with streptavidinecoupled horseradish peroxidase (Dako) giving a brown coloration to the Sertoli cells after reaction with diaminobenzidine. The cell nuclei were then stained with haematoxylin. The percentage of vimentin-negative cells in the Sertoli cell preparations was (mean S.D) 9·6 2·5% (n=27) in adult rats with no variation in either GnRHaor MAA-treated animals; it was 7·3 1·5, 11·0 2·2, 8·8 1·8, 8·9 1·8 and 8·2 1·6% in 10-, 20-, 30-, 40-and 60-day-old rats respectively (n=3 for each age).
Vimentin immunoreactivity was also used to identify and count Sertoli cells in histological sections. Since the number and/or volume of Sertoli cells, germ cells and intertitial cells may vary according to the above physiological and experimental conditions (Zhengwei et al. 1990 , Ariyaratne & Chamindrani Mendis-Handagama 2000 , the variations in the proportion of Sertolian tissue in the testis were roughly estimated by calculating the ratio of the number of Sertoli cells to the total number of cells counted on randomly chosen histological sections. In each experimental condition, at least 2000 cells were counted in randomly chosen microscopic fields at 1000 magnification. The cells were classified according to the following criteria: Sertoli cells (vimentin-positive cells within the seminiferous tubule), germ cells (vimentin-negative cells within the seminiferous tubule) and interstitial cells (vimentin-positive cells outside the tubules).
RNA extraction
Total RNA was extracted following a modification of Chomczynski and Sacchi's method (Chomczynski & Sacchi 1987) as previously described (Xie & Rothblum 1991) . Small pieces of freshly removed testicular tissue were disrupted in the RNA extraction solution with a polytron at 0 C.
Northern blot analysis
An RT-PCR-synthesised cDNA corresponding to nucleotides 798-1145 of the published sequence (Wong et al. 1993 ) (accession no. NM_053021) was used as a template for synthesis of the rat clusterin probe, labelled to a specific activity of 10 9 d.p.m. per microgram DNA with [ -32 P]dCTP by the random priming method (Megaprime DNA labelling kit, Amersham).
Total RNA was denatured by heating (95 C for 2 min) and resolved by electrophoresis (5 µg/lane) through 1% agarose gel containing 10% formaldehyde, then transferred onto a Hybond-N nylon membrane (Amersham). RNAs were cross-linked to the membranes by irradiation for 2 min with u.v. light and baking at 80 C for 2 h. Prehybridisation was performed for at least 2 h at 42 C in 50% formamide, SSPE (0·75 M NaCl, 20 mM NaPO 4 , pH 7·5 and 1 mM EDTA), 5
Denhardt's solution (0·1% Ficoll 400, 0·1% polyvinylpyrolidone and 0·1% BSA), 0·1% SDS, 10% dextran sulphate and 100 mg/ml denatured salmon sperm DNA. Hybridisation was carried out overnight at 42 C in the same buffer, containing 10 6 d.p.m. per millilitre 32 P-labelled rat clusterin probe. The nylon membranes were washed as follows: twice in 2 SSC (1 SSC: 150 mM NaCl, 15 mM sodium citrate, pH 7·4), 0·1% SDS at room temperature for 15 min each; then twice in 1 SSC, 0·1% SDS at 65 C for 15 min each; once in 0·5 SSC, 0·1% SDS at 65 C for 15 min; and in 0·1 SSC, 0·1% SDS at 65 C for 5 min. Autoradiograms were obtained after a 12 h exposure at 70 C to Hyperfilm M P (Amersham) with intensifying screens.
Thereafter, membranes were stripped by washing three times in water at 90 C and once in 1% SDS in water at 90 C, and hybridised as above with a synthetic oligonucleotide probe specific for 28S ribosomal RNA, labelled with T4 kinase and [ -32 P]ATP to a specific activity of 10 9 d.p.m. per microgram (Barbu & Dautry 1989) . The nylon membranes were washed as above and autoradiograms were obtained after 2 h exposure at 70 C to Hyperfilm M.P. (Amersham) with intensifying screens.
Autoradiograms were subjected to densitometry scanning and analysed with the NIH-IMAGE software. The data from the Northern blots were then expressed as clusterin signal/28S signal.
Competitive RT-PCR
This method is based upon the use of a synthetic RNA competitor which allows the monitoring of both reverse transcription and PCRs. The stability of this RNA is increased by incorporating modified nucleotides, making the competitor RNA resistant to ribonuclease.
Competitor synthesis and quantification
The construction of competitor RNAs with modified nucleotides was performed with the Ambion RT-PCR competitor construction kit (catalogue no. 1356) according to the manufacturer's instructions. Figure 1 shows the principles of RNA competitor synthesis ( Fig. 1A ) and of competitive RT-PCR (Fig. 1B) . The corresponding sequences, spanning different exons, (1) Location of the sequences used for competitor synthesis and the competitive RT-PCR: S1, sequence used for the forward primer of the competitive PCR (P1); S2, sequence used to create a deletion for the competitor synthesis; S3, sequence for the reverse primer of the competitive PCR; S4, sequence for the reverse primer of the reverse transcription for the competitive PCR; S5, sequence for the reverse primer of the reverse transcription for the synthesis of the competitor. (2) mRNA with the sequences S1-S5. (3) Reverse transcription from the mRNA for the synthesis of the template for the RNA competitor synthesis (P5 primer). (4) Synthesis of the template for the RNA competitor synthesis by PCR (P2 and P5 primers). (5) In vitro transcription with modified nucleotides form the cDNA template giving the RNA competitor. (B) Competitive RT-PCR; in the same tube, reverse transcription (P4 primer) and then PCR (P1 and P3 primers) were run in parallel from both the mRNA to be measured (1) and a known amount of RNA competitor (2).
were chosen according to the published rat clusterin (Wong et al. 1993 ; accession no. NM_053021) and rat SCF (Martin et al. 1990 ; accession no. NM_021843) cDNA sequences and are given in Table 1 . Sequence 1 (S1) was the sequence for the forward primer for the PCR (P1, see Fig. 1B ). Sequence 2 (S2), located downstream of S1, was used to construct the primer used for preparing the cDNA template for RNA competitor synthesis (P2). P2 included successively: the T7 polymerase promoting sequences, followed by a sequence of ten nucleotides including only G and A (5 -GGGAGAGGAG-3 ), allowing the beginning of the in vitro translation without the incorporation of modified nucleotides (c and u), followed by S1, followed by S2. The succession of S1-S2 induced a deletion between these two sequences. The deletion was of 75 bp for rClusterin and 107 bp for rSCF. Sequence 3 (S3), located in a downstream exon, was used for the reverse primer of the PCR (P3, see Fig. 1B ). Sequence 4 (S4) was used for the reverse primer of the reverse transcription (P4, see Fig. 1B ). Sequence 5 (S5) was used for the reverse primer used for the competitor template synthesis (P5). Two microlitres of reverse transcription products were subjected to PCR in a volume of 100 µl/tube containing 50 pmol P1 primer, 50 pmol P3 primer and 0·25 mM of each dNTP. After a denaturation step (5 min at 94 C), 2 units/tube of Taq polymerase (Roche) were added while the temperature was maintained at 80 C. The PCR was then performed for 40 cycles: 94 C for 1 min, 55 C for 2 min and 72 C for 1 min. The RT-PCR products obtained from the mRNA and from the synthetic RNA competitors were respectively 348 and 273 bp for rClusterin and 429 and 322 bp for rSCF. They were resolved with 1·5% agarose gel electrophoresis in the presence of ethidium bromide. Photographs of ethidium bromide u.v. fluorescence of the RT-PCR product bands were subjected to densitometry scanning and analysed with NIH-IMAGE software. The ratio of the RT-PCR products from the mRNA to the RT-PCR products from the competitor RNA was calculated and plotted against the initial competitor RNA concentration on a bi-logarithmic scale. The regression line was calculated and the initial concentration of mRNA was determined as the competitor concentration corresponding to ratio=1 (Fig. 2) .
The intra-and inter-assay coefficients of variation were respectively 14·4 and 29·3% for clusterin mRNA and 17·7 and 34·7% for SCF mRNA as determined by repeated measurements (both n=12) of the same RNA sample. 
Determination of the molecular forms of stem cell factor mRNA
Both the membrane-bound and the soluble forms of SCF are produced by the Sertoli cells (Marziali et al. 1993) . The mRNA of the soluble form is characterised by the presence of exon 6, which codes for a proteolytic site involved in the release of the extracellular C-terminal part of the molecule (Flanagan et al. 1991) . It can be distinguished from the mRNA of the membrane-bound SCF, which is characterised by a skipped exon 6, and by the smaller size of the RT-PCR products obtained with primers located on either side of exon 6. The primer for reverse transcription was chosen from the nucleotide sequence +766; +790 (exon 8), the forward primer for PCR, from the nucleotide sequence +275; +297 (exon 4) and the reverse primer for PCR, from the nucleotide sequence +691; +714 (exon 7) ( Table 1 ). The RT-PCR products were of 356 and 440 kb for the membranebound and the soluble forms of SCF respectively. The PCR products were resolved with 1·5% agarose gel electrophoresis in the presence of ethidium bromide. Photographs of ethidium bromide u.v. fluorescence of the RT-PCR product bands were subjected to densitometry scanning and analysed with NIH-IMAGE software. The ratio of membrane-bound SCF mRNA to soluble SCF mRNA was estimated from the ratio of the RT-PCR products.
Statistical analysis
The results of clusterin and SCF mRNA quantification were compared between groups by ANOVA followed by Fisher's PLSD test, after logarithmic transformation if required to equalise variance. P<0·05 was considered significant. Unless otherwise indicated, values are means S.E.M of three independent experiments.
Results
Validation of clusterin mRNA level as a stable marker of the RNA of Sertoli cell origin
The results of the measurement of clusterin mRNA levels relative to 28S RNA by Northern blot analysis of RNA extracted from purified Sertoli cell preparations or from whole testicle samples are shown in Figs 3A, 5A and 7A for the developmental study, the MAA treatment and the GnRHa treatment respectively; Figs 3B, 5B and 7B give the corresponding ratios of the number of Sertoli cells to the total number of cells counted in histological sections.
During post-natal development, the timing of the appearance of the germ cells was concordant with the description given by Clermont and Perrey (1957) and Marret et al. (1998) . Briefly, the most advanced germ cells were spermatogonia at 10 days, spermatocytes at 20 days, round spermatids at 30 days, elongated spermatids at 40 days and spermatozoa at 60 days. The number of germ cells increases dramatically during the development of spermatogenesis (Zhengwei et al. 1990 ) while the Sertoli cells stop dividing at about 15 days post-partum (Wang et al. 1989 , Zhengwei et al. 1990 ). In parallel, the volume of the Sertoli cells is altered during the first wave of spermatogenesis (Zhengwei et al. 1990) . Lastly, both the number and volume of interstitial cells increase between . These changes were reflected by an age-related decrease (P<0·0001) in the ratio of the number of Sertoli cells to the total number of cells counted on randomly chosen histological sections (Fig. 3B ) (see Materials and Methods section).
Clusterin mRNA levels (Fig. 3A) were low at 10 days of age and increased 4-fold by 20 days in RNA extracted from both whole testicle samples (P<0·0001) and purified Sertoli cell preparations (P<0·0001). Thereafter, the clusterin mRNA levels remained stable in RNA extracted from purified Sertoli cell preparations, but decreased 4-fold (P<0·0002) in whole testicle samples.
The histological features of rat testes following MAA administration were concordant with previous descriptions (Foster et al. 1987 , Bartlett et al. 1988 , Li et al. 1996 . Degeneration of pachytene spermatocytes was observed on day 3; degeneration of late spermatocytes and round spermatids associated with regeneration of pachytene spermatocytes appeared on day 7; and degeneration of elongated spermatids associated with regeneration of spermatocytes and round spermatids was seen on day 14 (Fig. 4) . Consequently, the ratio of the number of Sertoli cells to the total number of cells counted on histological sections increased about 2-fold (P<0·0001) after MAA treatment to a plateau between days 7 and 14 (Fig. 5B) . The clusterin mRNA levels (Fig. 5A) were unchanged in purified Sertoli cell preparations but increased (P=0·028) from day 3 onward in RNA from whole testicle samples.
The testicular weight decreased significantly (P<0·0001) from 1·73 0·02 g (mean S.E.M) before GnRHa injection to 1·55 0·02, 1·46 0·04 and 1·33 0·03 g at 2, 3 and 4 weeks respectively after administration of the long-acting preparation of -Trp6-GnRH to adult rats. An overall reduction in the number of germ cells was observed 2, 3 and 4 weeks after GnRHa administration (Fig. 6) , as expected (Pelletier et al. 1978 , Rivier et al. 1979 . At the dose used in this work, germ cell degeneration was partial: some elongated spermatids were still present at each time point studied. In parallel, the ratio of the number of Sertoli cells to the total number of cells counted on histological sections increased from day 14 onward (P<0·0001) after GnRHa treatment (Fig. 7B) . Clusterin mRNA levels (Fig. 7A ) remained stable in purified Sertoli cell preparations but increased steadily (P<0·0001) with time in whole testis samples.
Measurements of SCF and clusterin mRNA levels by competitive RT-PCR
In order to measure SCF and clusterin mRNA from small amounts of tissue, such as can be obtained from co-cultures of Sertoli and germ cells (Weiss et al. 1997) , seminiferous tubule cultures (Staub et al. 2000) or testicular biopsies, we developed a competitive RT-PCR procedure that monitored both the reverse transcription and the PCR steps.
The levels of SCF and clusterin mRNA measured in whole testis samples are given in panels A and B of Figs 8, 9 and 10 for developmental study, MAA treatment and GnRHa treatment respectively. The ratio of SCF mRNA levels to clusterin mRNA levels is given in the corresponding panel C.
During post-natal development, SCF mRNA levels decreased (P=0·0008) progressively with age from 7·3 2·6 10 6 copies/µg at 10 days, down to 0·25 0·08 10 6 copies/µg at 90 days (Fig. 8A ). In agreement with Northern blot analysis (Fig. 3A, d) , clusterin mRNA levels measured by RT-PCR were low (41 12 10 6 copies/µg) at 10 days of age, increased 6-fold (P<0·0001) at 20 days and decreased (P=0·0077) progressively thereafter down to 60 4 10 6 copies/µg at 90 days (Fig. 8B) . Because of the low value of clusterin mRNA levels at 10 days, the SCF mRNA/clusterin mRNA ratio was dramatically high on this day (176 35 10 3 ). Thereafter, the SCF mRNA/clusterin mRNA ratio tended to decrease slightly but not significantly (P=0·15) between 20 and 90 days, to 4·2 1·3 10 3 (Fig. 8C) . Following MAA administration, SCF mRNA levels increased (P<0·0001) 7-fold up to 1·10 0·03 10 6 copies/µg 14 days after injection (Fig. 9A) . Clusterin mRNA levels increased (P=0·0069) from 52 15 10 6 copies/µg to a maximum value of 691 329 10 copies/µg on day 7 and returned on day 14 to a value not different from control levels (Fig. 9B) . The SCF mRNA/ clusterin mRNA ratio remained stable until day 7 (2·7 0·5 10 3 ), then increased 3·7-fold (P=0·0153) on day 14 (Fig. 9C) .
After GnRHa treatment, SCF mRNA levels exhibited a biphasic pattern: a 5-fold increase between day 0 (0·18 0·02 10 6 copies/µg) and day 21, then a decrease between days 21 and 28 down to 0·58 0·06 10 6 copies/µg (P=0·0014) (Fig. 10A) . Clusterin mRNA levels increased 8-fold (P=0·0004), from 67 17 10 6 copies, over the 4 weeks after GnRHa injection (Fig. 10B) . The SCF mRNA/clusterin mRNA ratio (Fig. 10C ) was stable at 2·6 0·2 10 3 until day 21 then decreased (P=0·0047) 2·5-fold at day 28 after treatment.
Molecular forms of SCF mRNA
The average percentage of the membrane-associated form of SCF mRNA was 52·2 1·4% (n=42) and remained unchanged during post-natal development (P>0·73), after MAA (P>0·89) or after GnRHa administration (P>0·99) (data not shown).
Discussion
Only extreme non-physiological conditions, such as a temperature of 43 C, have been shown to alter the clusterin mRNA content of Sertoli cells in primary culture (Clark & Griswold 1997) . Thus, it seemed that clusterin mRNA might be a valuable candidate as a marker of the amount of mRNA of Sertoli cell origin (Maguire et al. 1997) . However, it was necessary to assess the stability of clusterin mRNA in situations that could be encountered in vivo in pathological or experimental cases. In the present work, the stability of clusterin mRNA levels in Sertoli cells was directly investigated by measuring them in purified rat Sertoli cell preparations in a set of situations characterised by dramatic or mild variations in the relative number and/or volume of somatic cells and/or germ cells; i.e. post-natal development, and MAA or GnRHa treatment.
It was found that the only situation studied in which the clusterin mRNA level in Sertoli cells varied was at 10 days post-partum. In contrast, clusterin mRNA levels varied greatly in the corresponding whole testicle extracts. However, these latter variations were rather parallel to the variations in the proportion of Sertolian tissue in the testes as estimated by the ratio of the number of Sertoli cells to the total number of cells counted on histological sections. These data indicated that the variations in clusterin mRNA level in the whole testicle samples were mainly, if not solely, due to the changes in their relative content in Sertolian tissue.
It must be underlined, that the ratio of the number of Sertoli cells to the total number of cells counted on histological sections was in no way aiming to be an estimation of the number of Sertoli cells in the testis; this requires much more sophisticated methodologies to be determined (Wreford 1995) . However, the ratio provides evidence that the proportion of Sertolian tissue in testis samples may vary greatly according to the different experimental/pathological conditions, even when the number of Sertoli cells remains unchanged. Similar variations were observed whether clusterin mRNA level was measured by Northern blot analysis or by competitive RT-PCR with RNA competitors; the latter method is much more sensitive than the former, enabling analysis from small amounts of tissue such as from clinical biopsies or Sertoli/germ cell co-cultures (Weiss et al. 1997 , Staub et al. 2000 . The use of clusterin mRNA as a marker of the amount of RNA of Sertoli cell origin is, however, limited to rats of 20 days old or more, since immature Sertoli cells do not express clusterin mRNA levels as high as those of mature Sertoli cells.
In the present study, SCF mRNA levels, measured by competitive RT-PCR in whole testicle samples, decreased during the development of spermatogenesis, as previously found by other authors (Hakovirta et al. 1999) . In contrast, they increased following administration of MAA and followed a biphasic pattern after GnRHa administration to adult rats. These changes were, however, the expected result of the variations in the relative amount of Sertolian tissue in the samples on the one hand, and the variations in the SCF mRNA contents of the Sertoli cells on the other. Therefore, once clusterin mRNA level had been validated as a marker of the proportion of RNA of Sertoli cell origin beyond 20 days of age, we expressed the SCF mRNA level relative to the clusterin mRNA level. This should represent the true variation in the expression of SCF by Sertoli cells.
It was thus found that, in the rat, SCF mRNA levels remained roughly stable from 20 days post-partum to adulthood. Hakovirta et al. (1999) suggested that the decrease in SCF mRNA levels observed during post-natal development might be due to dilution by RNA of germ cell origin; the present data clearly confirm this hypothesis. Furthermore, constant SCF expression during the establishment and maintenance of spermatogenesis fits quite well with the fundamental role played by stem cell factor at several steps of spermatogenesis (see Sette et al. 2000 for review) . More importantly, the present studies made it possible, for the first time, to quantify the 'physiological level' of SCF in the testis by measuring the Sertoli cell level of its mRNA. Indeed, for SCF, as for the other local regulatory molecules of spermatogenesis, no data are as yet available at the protein level. Hence, using quantitative RT-PCR to measure the level of an mRNA coding for a paracrine factor, in parallel with that of an mRNA coding for a molecule constitutively expressed by the cells producing the factor, should enable the 'physiological level' of many intra-testicular paracrine factors to be determined. Such a strategy should be particularly useful for physiopathological studies.
MAA administration led to the sequential disappearance of certain categories of germ cell, followed by replenishment of the seminiferous tubules by the next spermatogenic wave from day 7 onward. During the first week following treatment, there was no decrease in the SCF/ clusterin mRNA level ratio. It has been suggested that germ cell apoptosis in response to MAA is a direct response to toxicant insult to Sertoli cells and may entail regulation of both pro-survival and pro-apoptotic factors (Boekelheide et al. 2000) . If so, it seems rather unlikely that SCF is involved in such a response. Moreover, these studies indicated that lowering the number of germ cells supported by the Sertoli cells only marginally influenced the expression of SCF mRNA. This matches the results of the above 'corollary' developmental study showing that SCF mRNA levels were not significantly influenced by the progressive appearance of the various categories of germ cell between days 20 and 90. Likewise, no change in these levels was observed during the first 3 weeks after GnRHa injection, despite a general reduction in the number of germ cells. Taken together, these results indicate that, in vivo, germ cells probably do not regulate SCF production by the Sertoli cells greatly, if at all.
An intriguing result of the present studies was the 3·7-fold increase in the SCF/clusterin mRNA level ratio which occurred between 7 and 14 days following MAA injection. No consistent effects on SCF mRNA expression in the seminiferous epithelium were found after testosterone or oestradiol stimulation . Likewise, there was no effect of transforming growth factor (TGF) , TGF , tumour necrosis factor (TNF) or activin on SCF gene expression. To date, the most widely recognised positive and negative regulators of SCF expression by Sertoli cells in vitro are follicle-stimulating hormone (FSH; Goddard et al. 2001 , Rossi et al. 1993 ) and somatotrophin-release inhibitory factor (SRIF; Goddard et al. 2001) respectively, which act through the cAMP/ protein kinase A (PKA) pathway. Earlier studies showed that serum levels of FSH increase significantly within 24 h of treatment with MAA and increase further at 3 days, but return to control levels by day 7. Luteinising hormone (LH) and testosterone levels do not change at any time after treatment (Bartlett et al. 1988) . Therefore, it appears that the observed regeneration of pachytene spermatocytes and round spermatids between 7 and 14 days following MAA treatment is related more to increasing expression of Sertoli cell SCF than to any other putative regulatory factor studied so far.
Long-acting GnRH agonists first induce short-term stimulation of gonadotrophin secretion, followed by a sustained gonadotroph desensitisation, leading to low plasma gonadotrophin levels and decreased spermatogenesis. As expected, in the present study testis weight decreased and spermatogenesis was altered 14, 21 and 28 days after GnRHa administration. However, there was no decrease in the SCF/clusterin mRNA level ratio until between 3 and 4 weeks after injection. This late decrease in SCF mRNA level may be related to the progressive degenerative necrosis usually observed in Sertoli cells following GnRHa treatment (Pelletier et al. 1978 , van Kroonenburgh et al. 1986 . If so, this further confirms the robustness of clusterin as a marker of Sertoli cells in rat testis samples.
Both the increase in SCF mRNA level 14 days after MAA injection and the decrease 28 days after GnRHa treatment were late as compared with the plasma FSH increase 3 days after MAA and the FSH decrease 14 days after GnRHa previously reported (van Kroonenburgh et al. 1986 , Bartlett et al. 1988 . Taken together, these results indicate that there may not be as simple a relationship in vivo between FSH level and SCF gene expression as found in some in vitro systems (Rossi et al. 1993 , Goddard et al. 2001 . In summary, the present studies indicate that, under the above physiopathological conditions: (1) the measurement of mRNA coding for Sertoli cell derived SCF needs to be related to the amount of an mRNA constitutively expressed by the Sertoli cells; (2) the clusterin mRNA level is a good marker of the proportion of Sertolian tissue in testis samples at day 20 or later; (3) different experimental alterations of spermatogenesis are associated with different patterns of SCF mRNA level; and (4) the relationship between FSH and SCF in vivo is not as simple as that described in vitro. Long-term in vitro studies using co-cultures of Sertoli and germ cells (Weiss et al. 1997) or seminiferous tubule cultures (Staub et al. 2000) should shed more light on the regulation SCF production by FSH and/or other factors.
